The Egyptian Cardiac Rhythm Association

www.epsegypt.com
Follow us   

ECRA newsletter

Stay informed on our latest news!

Atrial fibrillation

Atrial fibrillation (AF) is not only the most common cardiac arrhythmia, but it is by far the most pertinent heart rhythm disorder associated with serious clinical issues as stroke, heart failure and increased risk of death. These complications are more likely to occur in less healthy individuals, such as in patients with heart failure, hypertension, age over 75, diabetes and stroke. In many cases, the AF can be treated with medication in the form of rate control or rhythm control. However in a significant proportion of patients, drugs are either ineffective or lead to unacceptable side effects. This had led electro physiologists to establish a technique that is capable of curing AF, “catheter ablation”. In the past few years, significant advancement has been made in the field of catheter ablation of AF, but there still is a room for improvement in the efficacy and the duration of this procedure. A better understanding of the pathophysiological mechanism involved may be the key in developing an ablation technique that could maximize both efficacy and efficiency.

This edition of EPS magazine discusses AF, its pathophysiology, catheter ablation as well as the latest tool in ablation, the cryoballoon.

Dr.Sarah Moharam
Cardiology Specialist,
National Heart Institute
 
Dr.Mervat Aboulmaaty
Professor of Cardiology,
Ain Shams University,
Editor in chief of epsegypt.com

1. Name: Stop AF: Cardiac Cryoablation system “Medtronic”
    By: Dr.Ahmed Abdel Aziz,
          Professor of Critical Care Medicine,
          Critical Care Department.

Download Link: Here


2. Name: Management of atrial fibrillation in emergency department
    By: Dr.Wael Chalak,
          Chief of cardiology division,
         Faculty of Medical Sciences-Lebanese University.

Download Link: Here


3. Name: Design of The Future Antiarrhythmic Trials Based on Data from Implantable Devices: Focus on Silent Atrial Fibrillation
    By: Dr. Mohammad Shenasa,
         O’Connor Hospital San Jose.

Download Link: Here